UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000005556
Receipt No. R000006584
Scientific Title Phase I / II study for appropriate dose of Erlotinib in patients with lung adenocarcinoma having the sensitive mutation to epidermal growth factor receptor (EGFR) - tyrosine kinase inhibitor (TKI)
Date of disclosure of the study information 2011/05/10
Last modified on 2019/03/30 15:33:31

No. Disposal Last modified on Item of update
1 Insert 2011/05/05 15:30:23
2 Update 2011/05/23 12:28:37 Email1
3 Update 2011/08/24 20:19:40 Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2011/08/24 20:21:37 Recruitment status
5 Update 2011/11/05 12:53:38 Results
6 Update 2012/05/05 10:49:24 Results
7 Update 2013/06/07 20:17:39 Results
8 Update 2013/08/25 10:57:27 Email
9 Update 2013/08/25 10:58:09 Recruitment status
10 Update 2013/11/23 13:27:02 Recruitment status
Results
11 Update 2013/11/23 16:36:10 Results
12 Update 2013/12/28 14:58:29 Results
Results
13 Update 2014/05/16 03:41:24


14 Update 2015/05/11 10:59:02 Results
Results
15 Update 2015/11/12 20:00:58 Last follow-up date
Results
Results
16 Update 2016/05/05 10:49:17 Name of primary sponsor
Institute
Department
Organization
17 Update 2016/05/05 10:53:38 Results
Results
18 Update 2017/05/08 11:00:14 Results
Results
19 Update 2018/05/09 16:37:44 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
URL related to results and publications
20 Update 2019/03/30 15:27:11 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
21 Update 2019/03/30 15:31:07 Recruitment status
Date of IRB
22 Update 2019/03/30 15:33:31 Number of participants that the trial has enrolled
Results date posted
Results Delayed
Results Delay Reason
Results Delay Reason


Contact us.